Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

761
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
761
Fetal Circulation01:14

Fetal Circulation

2.7K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.7K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

182
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
182
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

321
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
321

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide association studies of infant and toddler temperament in European and multi-ancestry populations.

Nature human behaviour·2026
Same author

Characterising the association between posterior parietal metabolite levels and cortical macrostructure in a cohort spanning childhood to adulthood.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

In Vivo Glx Measurements From GABA-Edited HERMES at 3 T Are Not Consistent With Those From Short-TE PRESS Across Scanners, Brain Regions, Diagnostic and Age Groups.

NMR in biomedicine·2025
Same author

7 Tesla fMRI characterisation of the cortical-depth-dependent BOLD response in early human development.

bioRxiv : the preprint server for biology·2025
Same author

Ultra-High Field 7T MRI in a Drug-Resistant Pediatric Epilepsy Cohort: Image Comparison and Radiologic Outcomes.

Neurology·2025
Same author

Partnership delivery of evidence-based therapy intervention to improve upper-limb function: a retrospective analysis.

BMJ paediatrics open·2025

Related Experiment Video

Updated: Jan 22, 2026

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain
14:26

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain

Published on: December 20, 2012

15.3K

Psychotropic medication and the fetal brain.

Oliver Gale-Grant1, Tomoki Arichi2,3,4

  • 1Department of Forensic and Neurodevelopmental Sciences, King's College London, London, UK.

The Journal of Physiology
|January 21, 2026
PubMed
Summary
This summary is machine-generated.

Psychotropic medication use during pregnancy may impact infant neurodevelopment. Research is needed to understand subtle effects of in utero exposure on the developing brain.

Keywords:
magnetic resonance imagingneurodevelopmentpharmacologyplacentapregnancy

More Related Videos

Zika Virus Infection of Cultured Human Fetal Brain Neural Stem Cells for Immunocytochemical Analysis
10:27

Zika Virus Infection of Cultured Human Fetal Brain Neural Stem Cells for Immunocytochemical Analysis

Published on: February 5, 2018

6.9K
Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
13:12

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping

Published on: August 12, 2019

46.4K

Related Experiment Videos

Last Updated: Jan 22, 2026

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain
14:26

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain

Published on: December 20, 2012

15.3K
Zika Virus Infection of Cultured Human Fetal Brain Neural Stem Cells for Immunocytochemical Analysis
10:27

Zika Virus Infection of Cultured Human Fetal Brain Neural Stem Cells for Immunocytochemical Analysis

Published on: February 5, 2018

6.9K
Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
13:12

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping

Published on: August 12, 2019

46.4K

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pharmacology

Background:

  • Psychotropic medications are frequently prescribed to pregnant women for mental health conditions.
  • While gross birth defects are rare, subtle neurodevelopmental effects from prenatal exposure are a growing concern.
  • Increased prescribing rates necessitate a deeper understanding of potential risks.

Purpose of the Study:

  • To review studies on early life brain changes associated with prenatal psychotropic medication exposure.
  • To discuss potential biological mechanisms underlying these neurodevelopmental effects.
  • To identify key areas for future research in this field.

Main Methods:

  • Literature review of current studies.
  • Analysis of animal models, human neuroimaging (MRI), and behavioral studies.
  • Examination of proposed mechanistic pathways.

Main Results:

  • Evidence suggests subtle, not gross, neurodevelopmental alterations in infants exposed to psychotropic medications in utero.
  • Animal and human studies indicate potential impacts on brain structure and function.
  • Further research is required to fully elucidate these effects.

Conclusions:

  • Prenatal exposure to psychotropic medications may have subtle adverse effects on early neurodevelopment.
  • Understanding these consequences is critical due to rising prescription rates.
  • Future research should focus on quantifying these effects and their underlying mechanisms.